Optimi Health (FRA:8BN0) Moat Score: 1/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8BN0 Optimi Health Corp FRA:8BN0
35 GF Score
Price €3.87
GF Value €3.51
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Optimi Health Moat Score?

Optimi Health FRA:8BN0 +0.65% 35 Moat Score is 1 as of Jul. 14, 2026. GuruFocus rates FRA:8BN0 with a GF Score™ of 35/100 and a GF Value™ of €3.51 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Optimi Health ranks better than 76.24% on this metric.

Optimi Health has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Optimi Health has No Moat: Optimi Health Corp is in the early stages of development with no discernible competitive advantages. It lacks market leadership, proprietary technology, and significant regulatory barriers, making its competitive position very weak.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Optimi Health might have No Moat - Very weak/transient advantages.

Optimi Health  (FRA:8BN0) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Optimi Health Moat Score Related Terms

FRA:8BN0 vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimi Health Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Moat Score distribution charts can be found below:

* The bar in red indicates where Optimi Health's Moat Score falls into.


FRA:8BN0
35GF Score
Optimi Health Corp FRA:8BN0
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Optimi Health (FRA:8BN0) has a Moat Score of 1 as of Jul. 14, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Optimi Health ranks #245 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 23.8%.
Is Optimi Health's Moat Score too high?
Optimi Health's current Moat Score is 1. Based on the distribution chart, Optimi Health ranks #245 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Optimi Health has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #245 out of 1031 companies for Moat Score. This places Optimi Health in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Optimi Health's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (FRA:8BN0) is currently considered Fairly Valued. The stock's GF Value™ is €3.51, compared to a current price of €3.87 — trading 10.3% above its estimated fair value. The current Moat Score is 1. Optimi Health's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Optimi Health (FRA:8BN0), the current Moat Score is 1 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Optimi Health (FRA:8BN0) Overvalued in 2026?

Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued. The current stock price of €3.87 is trading 10.3% above its estimated GF Value™ of €3.51. GuruFocus considers Optimi Health to be Fairly Valued.

Key valuation signals for FRA:8BN0:

  • Moat Score: 1
  • GF Value™: €3.51 vs. price of €3.87 (10.3% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the FRA:8BN0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optimi Health Business Description

Address 269 David Brown Way, Po Box 728, Princeton, BC, CAN, V0X 1W0
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
35GF Score

Get the complete analysis for FRA:8BN0

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.87
Price
€3.51
GF Value